Figure 2

Representative results of the western blot analysis of the intrahepatic cholangiocarcinoma specimens. Eight patients with positive (+) or negative (−) p-AKT1 or p-MTOR expression as assessed by immunohistochemistry were analyzed by western blot analysis to validate these antibodies.